iNtRON Biotechnology Inc Free Cash Flow Generation Index

Latest as of March 2025: 0.83x

iNtRON Biotechnology Inc free cash flow generation index. iNtRON Biotechnology Inc (048530) has a Free Cash Flow Generation Index of 0.83x as of March 2025. Free cash flow of ₩1.62 Billion represents 1% of operating cash flow (₩1.94 Billion).

FCF Generation Index

0.83x
Free Cash Flow / Operating CF

Free Cash Flow

₩1.62 Billion
KRW

Operating Cash Flow

₩1.94 Billion
KRW

Capital Expenditures

₩321.62 Million
KRW

Free Cash Flow Generation Index of iNtRON Biotechnology Inc (2015–2023)

Free cash flow generation index of iNtRON Biotechnology Inc from 2015 to 2023. Historical FCF Generation Index trend for iNtRON Biotechnology Inc across 6 annual periods. See iNtRON Biotechnology Inc (048530) flexibility index to measure the company's free cash flow as a share of total liabilities.

iNtRON Biotechnology Inc Free Cash Flow Generation Index by Year (2015–2023)

iNtRON Biotechnology Inc free cash flow generation index by year from 2015 to 2023. Year-by-year Free Cash Flow Generation Index for iNtRON Biotechnology Inc. For the full cash flow conversion analysis, see cash flow conversion of iNtRON Biotechnology Inc.

Year FCG Index Free Cash Flow (KRW) Operating CF Capital Expenditures YoY Change
2023 -2.06x ₩-6.43 Billion ₩3.12 Billion ₩9.55 Billion ▼ -467.1%
2022 0.56x ₩3.36 Billion ₩5.98 Billion ₩2.23 Billion ▼ -28.6%
2021 0.79x ₩12.98 Billion ₩16.47 Billion ₩3.05 Billion ▲ +429.7%
2020 0.15x ₩1.06 Billion ₩7.13 Billion ₩4.85 Billion ▼ -86.9%
2018 1.13x ₩4.75 Billion ₩4.20 Billion ₩550.58 Million ▼ -76.0%
2015 4.71x ₩8.00 Billion ₩1.70 Billion ₩6.30 Billion —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).